BioSpectrum Asia

For over 75 years, Alcon Inc. has been a global leader in eye care, dedicated to improving vision health and empowering eye care professionals. Operating in 56 countries and serving patients in 140, Alcon offers innovative solutions in surgical and vision care, addressing critical eye health challenges. In an interview with BioSpectrum Asia, Jason Hoffe, Vice President of APAC Vision Care at Alcon, shares insights into the evolving eye care landscape, unmet needs in the region, and how Alcon’s cutting-edge technologies and collaborative initiatives are shaping the future of eye health in Asia-Pacific.

Porton Pharma Solutions and Dragon Sail Pharmaceutical (Shanghai) have signed a strategic cooperation agreement in Guilin, southern of China. This collaboration aims to carry out in-depth cooperation in the research, development, production, and supply chain integration of antibody-drug conjugates (ADC).  https://lnkd.in/dKfhXxFZ Porton Pharma Solutions Ltd. #drugconjugates #Pharmaceuticles #Pharmasolutions

Fujirebio Holdings, a wholly-owned subsidiary of H.U. Group Holdings, Inc., and Eisai Co., in Japan, have entered into a Memorandum of Understanding (MoU) for the joint research and social implementation of novel blood-based biomarkers in the field of neurodegenerative diseases. https://lnkd.in/dBi8yXPt Fujirebio Eisai Co., Ltd. #diagnostictechnologies #researchanddevelopment

China-based Bio-Thera Solutions Inc., a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and a pipeline of biosimilars, has partnered with Tabuk Pharmaceutical Manufacturing Company (a fully-owned subsidiary of Astra Industrial Group), a leading pharmaceutical company in the Middle East and North Africa (MENA) region, for BAT2206, its ustekinumab biosimilar, under which Tabuk will have exclusive rights to manufacture, distribute and market the drug in Saudi Arabia. https://lnkd.in/dUuFVxYQ Bio-Thera Solutions Tabuk Pharmaceuticals Manufacturing Company #biosimilar #Pharmaceuticalindustry #Pharmabusiness

South Korea-based startup Medit has launched a mobile app, MEDIT M. This much-anticipated release addresses key features requested by dental professionals and aims to improve collaboration and efficiency between clinics and labs. https://lnkd.in/d8yfStmT Medit #medtech #medtechstartup #dentalcare #dentalprofessionals

The Australian government is investing $18.5 million to help eight Australian startup companies to commercialise their research and help turn their discoveries into new medicines and treatment tools for cancer, pregnancy complications, eye damage, and other conditions. https://lnkd.in/dFFMwc7n Mirugen OncoRes Medical Baymatob #MedicalResearch #Medtechstartup #Australia

South Korea-based SK bioscience and French pharmaceutical firm Sanofi have announced the signing of an expanded agreement to co-develop next-generation pneumococcal conjugate vaccines (PCVs) for both paediatric and adult populations, with the potential to provide broader protection than those currently licensed. https://lnkd.in/dAb_29-Y SK bioscience Sanofi #Vaccinedevelopment #Pharmaindustry

Merck, known as MSD outside of the United States and Canada, and Hansoh Pharma, a Chinese biopharmaceutical company, have entered into an exclusive global license agreement for HS-10535, an investigational preclinical oral small molecule GLP-1 receptor agonist. https://lnkd.in/dxQT2Nij Merck Life Science Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Dean Y. Li, MD, PhD eliza sun #biotechcompany #pharmaindustry #cardiometabolicdiseases

Lakeside Holding, a US-based cross-border supply chain solution provider with a unique focus on the Asia-Pacific market has announced that Hupan Pharmaceutical has signed a Sales Agreement with Sinopharm Holding Hubei New Special Medicine Co., a subsidiary of Sinopharm Group, based in China. https://lnkd.in/dmwfdHZX Sinopharm #Pharmasupplychain #Pharmabusiness #pharmaindustry

US-based Thermo Fisher Scientific has introduced the Applied Biosystems MagMAX Sequential DNA/RNA kit to enable clinical and translational researchers to conduct comprehensive DNA and RNA genomic analysis and streamline detection of genetic abnormalities found in hematological malignancies. https://lnkd.in/dyQtnK59 Thermo Fisher Scientific #genomic #leukemia #CancerCare #Cancerresearch